EUVIMEDEUVIMED entdecken
Crossref

International experts consensus on optimal central vascular access device selection and management for patients with cancer

Mohammad Jahanzeb, Ching-Yang Wu, Howard Lim, Kei Muro, Lichao Xu, Manjiri Somashekhar, S P Sampige Prasannakumar Somashekhar, Xiaotao Zhang, Xiaoxia Qiu, Ying Fu, Mauro Pittiruti iD

The Journal of Vascular Access · 2025-09 · 26 (5) · 1447-1458

DOI: 10.1177/11297298241300792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, online erschienen am 02.12.2024. Verfasst von Mohammad Jahanzeb und 10 weiteren Autor:innen. Beteiligte Einrichtung: Creative Precision Oncology, an OncAdvisor Practice, Boca Raton, FL, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Catheterization, Central Venous, Catheters, Indwelling, Central Venous Catheters. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In patients with cancer, the choice of an appropriate venous access device is crucial for effective treatment, minimizing complications, and reducing healthcare costs. Key management decisions, such as the timing of device removal post-therapy, can impact clinical outcomes. As current international guidelines lack specific directives for these issues, a global consensus of experts, representing different countries, was deemed appropriate.

Methods

A panel of 11 experts from three continents, including oncologists and healthcare professionals, was chosen. After a comprehensive review of clinical trials and guidelines on central venous access devices (CVAD) in oncology published between January 2013 and December 2023, the panel developed and voted on specific recommendations for the selection and management of CVADs in patients with cancer, during a 2-day meeting.

Results

The panel reached consensus on 10 issues concerning (a) indications for a CVAD, (b) available options for CVADs, (c) role of the staff and patients in the choice of CVAD, (d) factors influencing the selection of a port over an external catheter, (e) logistical requirements for port and external catheter insertion, (f) stakeholders responsible for port and external catheter insertion, (g) factors determining the removal of a port after completing the definitive therapy, and (h) recommended frequency of flushing when the CVAD is not in use.

Conclusions

The results of the consensus may offer healthcare professionals a global view of some critical issues concerning CVADs for cancer therapy, helping to establish recommendations for local clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCatheterization, Central VenousCatheters, IndwellingCentral Venous CathetersDevice RemovalNeoplasmsHumansClinical Decision-MakingConsensusEquipment DesignRisk Factors

Stichwörter der Autor:innen

Central venous access devicecentrally inserted central catheterfemoral inserted central catheterperipherally inserted central cathetertotally implanted venous access device

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Creative Precision Oncology, an OncAdvisor Practice, Boca Raton, FL, USA.
  • Chang Gung Memorial Hospital, Linkou, Taiwan.
  • BC Cancer, Vancouver, Vancouver, BC, Canada.
  • Aichi Cancer Center Hospital, Nagoya, Japan.
  • Fudan University Shanghai Cancer Center, Shanghai, China.
  • Aster International Institute of Oncology, Bangalore, Karnataka, India.

ORCID-Profile: Mauro Pittiruti

Zitieren

APA

Jahanzeb, M., Wu, C. Y., Lim, H., Muro, K., Xu, L., Somashekhar, M., Sampige Prasannakumar Somashekhar, S. P., Zhang, X., Qiu, X., Fu, Y., & Pittiruti, M. (2025). International experts consensus on optimal central vascular access device selection and management for patients with cancer. The Journal of Vascular Access, 26(5), 1447-1458. https://doi.org/10.1177/11297298241300792

Vancouver

Jahanzeb M, Wu CY, Lim H, Muro K, Xu L, Somashekhar M, et al. International experts consensus on optimal central vascular access device selection and management for patients with cancer. The Journal of Vascular Access. 2025;26(5):1447-1458. doi:10.1177/11297298241300792

BibTeX
@article{Jahanzeb2025,
  author = {Jahanzeb, Mohammad and Wu, Ching-Yang and Lim, Howard and Muro, Kei and Xu, Lichao and Somashekhar, Manjiri and Sampige Prasannakumar Somashekhar, S P and Zhang, Xiaotao and Qiu, Xiaoxia and Fu, Ying and Pittiruti, Mauro},
  title = {International experts consensus on optimal central vascular access device selection and management for patients with cancer},
  journal = {The Journal of Vascular Access},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {1447--1458},
  doi = {10.1177/11297298241300792}
}
Kostenlos starten →